InsidersTradesSigma
Track the 인벤테라 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 인벤테라 has logged 8 insider filings. Market capitalisation: €60.6bn. The latest transaction was disclosed on 9 April 2026 (Purchase). Among the most active insiders: 신태현. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations
Inventaera is a healthcare and pharmaceutical company listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.